Evidence map›Paper›PMID 42645778›Full record

ArticleInterdisciplinary sciences, computational life sciences2026

3D Geometric Equivariant Graph Neural Networks with Contrastive Learning for Protein-Ligand Binding Affinity Prediction.

Gaili Li, Yongna Yuan, Xiuping Chen, Ping Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gaili LiSchool of Mathematics and Computer Science, Northwest Minzu University, Chengguan, Lanzhou, 730030, Gansu, China. ligl2021@lzu.edu.cn.ORCID http://orcid.org/0000-0002-9142-8170
Yongna YuanSchool of Information science and Engineering, Lanzhou University, Chengguan, Lanzhou, 730000, Gansu, China.
Xiuping ChenSchool of Mathematics and Computer Science, Northwest Minzu University, Chengguan, Lanzhou, 730030, Gansu, China.
Ping WangSchool of Traffic and Transportation, Lanzhou Jiaotong University, Anning, Lanzhou, 730070, Gansu, China.

Funding

the National Ethnic Affairs Commission of China Grant No. 1001850383
6 · The paper itself

Abstract

Protein-Ligand Binding Affinity (PLBA) prediction is a key task in computer aided drug design, underpinning virtual screening, lead optimization, and drug repurposing. Despite recent advances in deep learning, many existing methods fail to fully exploit three-dimensional (3D) geometric information and remain sensitive to conformational variability. To address these limitations, we propose 3D-GEGCL, a framework that integrates 3D geometrically equivariant graph neural networks with self-supervised contrastive learning for robust and accurate PLBA prediction. Protein-ligand complexes are represented as atomic-level 3D geometric graphs and encoded using an E(3)-equivariant network to ensure physical consistency under rotations and translations, while contrastive learning enforces representation consistency across geometrically perturbed views. Comprehensive evaluations conducted on the PDBbind v2019 and CSAR-HiQ benchmarks reveal that 3D-GEGCL achieves superior performance over existing leading methods across a range of assessment criteria. Additional ablation analyses validate the synergistic roles of geometric equivariance and contrastive learning, underscoring the robustness and broad applicability of the introduced framework. Implementation scripts for the various model components are publicly accessible via https://github.com/ligaili01/3D-GEGCL .

Indexed as

Contrastive learningGeometric equivarianceGraph neural networksProtein–ligand binding affinity predictionThree-dimensional molecular representation

Identifiers

PMID42645778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.